Annual Cash & Cash Equivalents
$6.82 M
-$12.40 M-64.51%
December 1, 2022
Summary
- As of March 13, 2025, CERO annual cash & cash equivalents is $6.82 million, with the most recent change of -$12.40 million (-64.51%) on December 1, 2022.
- During the last 3 years, CERO annual cash & cash equivalents has fallen by -$12.40 million (-64.51%).
- CERO annual cash & cash equivalents is now -64.51% below its all-time high of $19.22 million, reached on December 1, 2021.
Performance
CERO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.38 M
-$266.80 K-7.32%
September 1, 2024
Summary
- As of March 13, 2025, CERO quarterly cash and cash equivalents is $3.38 million, with the most recent change of -$266.80 thousand (-7.32%) on September 1, 2024.
- Over the past year, CERO quarterly cash and cash equivalents has stayed the same.
- CERO quarterly cash and cash equivalents is now -37.27% below its all-time high of $5.39 million, reached on March 1, 2023.
Performance
CERO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CERO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -64.5% | 0.0% |
| 3 y3 years | -64.5% | 0.0% |
| 5 y5 years | -64.5% | 0.0% |
CERO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.5% | at low | -37.3% | at low |
| 5 y | 5-year | -64.5% | at low | -37.3% | at low |
| alltime | all time | -64.5% | at low | -37.3% | at low |
CERo Therapeutics Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.38 M(-7.3%) |
| Jun 2024 | - | $3.65 M(-20.6%) |
| Mar 2024 | - | $4.59 M(-14.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $5.39 M |
| Dec 2022 | $6.82 M(-64.5%) | - |
| Dec 2021 | $19.22 M | - |
FAQ
- What is CERo Therapeutics Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings annual cash & cash equivalents year-on-year change?
- What is CERo Therapeutics Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings quarterly cash and cash equivalents year-on-year change?
What is CERo Therapeutics Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of CERO is $6.82 M
What is the all time high annual cash & cash equivalents for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high annual cash & cash equivalents is $19.22 M
What is CERo Therapeutics Holdings annual cash & cash equivalents year-on-year change?
Over the past year, CERO annual cash & cash equivalents has changed by -$12.40 M (-64.51%)
What is CERo Therapeutics Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CERO is $3.38 M
What is the all time high quarterly cash and cash equivalents for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high quarterly cash and cash equivalents is $5.39 M
What is CERo Therapeutics Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, CERO quarterly cash and cash equivalents has changed by $0.00 (0.00%)